W
Wei Qu
Researcher at China Pharmaceutical University
Publications - 105
Citations - 1924
Wei Qu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 18, co-authored 94 publications receiving 1233 citations.
Papers
More filters
Journal ArticleDOI
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
TL;DR: This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs), and analyzes some MTDLs research cases for several complex diseases in recent years and the physicochemical properties of 117 clinical multitarget drugs, with the aim of revealing the trends and insights of the potential use of MT DLs.
Journal ArticleDOI
Medicinal uses, phytochemistry and pharmacology of the genus Uncaria.
TL;DR: Preliminary investigations on pharmacological properties of the Uncaria species have enlightened their efficacious remedy for hypertension, asthma, cancer, diabetes, rheumatism and neurodegenerative diseases.
Journal ArticleDOI
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
TL;DR: Concerns and opinions about development of donepezil derivatives, designing of MTDLs, and perspectives for AD treatments are discussed in final part.
Journal ArticleDOI
Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery.
Xueyang Jiang,Tingkai Chen,Junting Zhou,Siyu He,Hongyu Yang,Yao Chen,Wei Qu,Feng Feng,Haopeng Sun +8 more
TL;DR: In vivo studies confirmed that compound 2f significantly ameliorated the cognitive disorders in scopolamine-treated ICR mice and less hepatotoxicity than tacrine, and provides new leads for assessment of GSK-3β and AChE pathway dual inhibition as a promising strategy for AD treatment.
Journal ArticleDOI
Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Huan Liang,Zhanwei Zhou,Renjie Luo,Mangmang Sang,Bowen Liu,Minjie Sun,Wei Qu,Feng Feng,Wenyuan Liu +8 more
TL;DR: Tumor-specific activated photodynamic therapy using an oxidation-regulating strategy is described, achieving superior anti-tumor efficacy by reducing intracellular antioxidant levels.